Telomere Length and Genetic Anticipation in Lynch Syndrome

Telomere length variation has been associated with increased risk of several types of tumors, and telomere shortening, with genetic anticipation in a number of genetic diseases including hereditary cancer syndromes. No conclusive studies have been performed for Lynch syndrome, a hereditary colorectal cancer syndrome caused by germline mutations in the DNA mismatch repair genes. Here we evaluate telomere length in Lynch syndrome, both as a cancer risk factor and as a mechanism associated with anticipation in the age of cancer onset observed in successive generations of Lynch syndrome families. Leukocyte telomere length was measured in 244 mismatch repair gene mutation carriers from 96 Lynch syndrome families and in 234 controls using a monochrome multiplex quantitative PCR method. Cancer-affected mutation carriers showed significantly shorter telomeres than cancer-free mutation carriers. In addition, cancer-affected carriers showed the most pronounced shortening of telomere length with age, compared with unaffected carriers. The anticipation in the age of cancer onset observed in successive generations was not associated with telomere shortening, although, interestingly, all mother-son pairs showed telomere shortening. In conclusion, cancer-affected mismatch repair gene mutation carriers have distinct telomere-length pattern and dynamics. However, anticipation in the age of onset is not explained by telomere shortening. Pending further study, our findings suggest that telomere attrition might explain the previously reported dependence of cancer risk on the parent-of-origin of mismatch repair gene mutations.

[1]  E. Guinó,et al.  Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome , 2012, European Journal of Human Genetics.

[2]  Margaret A. Strong,et al.  Extreme Telomere Length Dimorphism in the Tasmanian Devil and Related Marsupials Suggests Parental Control of Telomere Length , 2012, PloS one.

[3]  N. Rothman,et al.  Association of Leukocyte Telomere Length with Colorectal Cancer Risk: Nested Case–Control Findings from the Shanghai Women's Health Study , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[4]  S. Savage,et al.  Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. , 2012, Mutation research.

[5]  J. M. Taylor,et al.  Bayesian Modeling for Genetic Anticipation in Presence of Mutational Heterogeneity: A Case Study in Lynch Syndrome , 2011, Biometrics.

[6]  M. Ponz de Leòn,et al.  Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome , 2011, Cancer.

[7]  N. Royle,et al.  Deficiency in DNA mismatch repair increases the rate of telomere shortening in normal human cells , 2011, Human mutation.

[8]  M. Urioste,et al.  Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer , 2011, PLoS genetics.

[9]  S. Ballereau,et al.  TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres , 2011, Gut.

[10]  Q. Wei,et al.  Shortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis , 2011, PloS one.

[11]  R. Pfeiffer,et al.  The Association of Telomere Length and Cancer: a Meta-analysis , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[12]  G. Giles,et al.  Dependence of colorectal cancer risk on the parent‐of‐origin of mutations in DNA mismatch repair genes , 2011, Human mutation.

[13]  S. Gruber,et al.  A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome , 2010, Genetic epidemiology.

[14]  R. Bertorelle,et al.  Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers , 2010, British Journal of Cancer.

[15]  M. Frazier,et al.  Microsatellite instability in the peripheral blood leukocytes of HNPCC patients , 2010, Human mutation.

[16]  J. Ford,et al.  Longer Relative Telomere Length in Blood from Women with Sporadic and Familial Breast Cancer Compared with Healthy Controls , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[17]  H. Pickett,et al.  Human telomeres that contain (CTAGGG)n repeats show replication dependent instability in somatic cells and the male germline , 2009, Nucleic acids research.

[18]  M. Blasco,et al.  MSH2 deficiency abolishes the anticancer and pro‐aging activity of short telomeres , 2009, Aging cell.

[19]  I. Bernstein,et al.  Role for genetic anticipation in Lynch syndrome. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  S. Gruber,et al.  Anticipation in lynch syndrome: still waiting for the answer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Richard M. Cawthon,et al.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method , 2009, Nucleic acids research.

[22]  I. Bernstein,et al.  A Parametric Model for Analyzing Anticipation in Genetically Predisposed Families , 2009, Statistical applications in genetics and molecular biology.

[23]  M. Trková,et al.  Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age , 2007, Cancer.

[24]  D. Malkin,et al.  Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. , 2007, Cancer research.

[25]  A. Piepoli,et al.  Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC , 2007, Clinical genetics.

[26]  Yen-Pei Christy Chang,et al.  Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  I. Dokal,et al.  Dyskeratosis congenita: telomerase, telomeres and anticipation. , 2005, Current opinion in genetics & development.

[28]  P. Hutter,et al.  Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer , 2005, Human Genetics.

[29]  J. Londoño-Vallejo Telomere length heterogeneity and chromosome instability. , 2004, Cancer letters.

[30]  E. Montgomery,et al.  Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis , 2004, Clinical Cancer Research.

[31]  H. Pickett,et al.  Telomere instability detected in sporadic colon cancers, some showing mutations in a mismatch repair gene , 2004, Oncogene.

[32]  T. Vulliamy,et al.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.

[33]  R. Scott,et al.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. , 2001, American journal of human genetics.

[34]  J. Shay,et al.  Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals , 1998, Human Genetics.

[35]  N. Petrelli,et al.  Establishment of a hereditary nonpolyposis colorectal cancer registry , 1996, Diseases of the colon and rectum.

[36]  A. Cats,et al.  Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. , 1994, Gut.

[37]  C. Boland,et al.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. , 1993, Gastroenterology.